Perfuze

Series-A
perfuze.com Biotech & Healthcare
Total Funding $29M
Latest Round $26M Series-A
Last Announced Feb 9, 2022
Investors Undisclosed
Decision Makers 6 Verified

About Perfuze

Developing innovative catheter technology to treat acute ischemic stroke, providing superior clinical outcomes in shorter procedural times.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website perfuze.com
Domain Registered Date Mar 27, 2018

Social & Network Presence

X / Twitter Profile @PerfuzeStroke (18 followers) Created on Apr 2025
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Milestone

    X account created (@PerfuzeStroke)

    18 followers

  2. Capital Raise

    Raised $26,000,000 · Series-A

    startupintros.com

  3. Capital Raise

    Raised $3,000,000 · Seed

    startupintros.com

  4. Milestone

    Website domain registered

    perfuze.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Perfuze.

Funding History

2 Rounds
Series-A · Feb 9, 2022
Seed · Jan 1, 2019

Founders & Leadership

2

Liam Mullins

co-founder

Work email & phone locked Unlock →

Wayne Allen

co-founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts